Press release
Surgical Site Infections Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
Surgical Site Infections Overview
Surgical site infections (SSIs) are defined as infections occurring up to 30 days after surgery (or up to one year after surgery in patients receiving implants) and affecting either the incision or deep tissue at the operation site. Despite improvements in prevention, SSIs remain a significant clinical problem as they are associated with substantial mortality and morbidity and impose severe demands on healthcare resources.
"Surgical Site Infections Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Surgical Site Infections Market.
The Surgical Site Infections Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Surgical Site Infections Pipeline Report: https://www.delveinsight.com/report-store/surgical-site-infections-ssi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Surgical Site Infections treatment therapies with a considerable amount of success over the years. Surgical Site Infections Key players such as - Covira Surgical, Sonoran Biosciences, Eupraxia Pharmaceuticals, Destiny Pharma, POLYPID, and others, are developing therapies for the Surgical Site Infections treatment
• Surgical Site Infections Emerging therapies such as - CS-0003, SBG003, EP 201, XF-73, D-PLEX, and others are expected to have a significant impact on the Surgical Site Infections market in the coming years.
• In January 2023, PolyPid Ltd. provided a positive regulatory update for D-PLEX100 for the prevention of abdominal colorectal surgical site infections (SSIs). Following a recent type D meeting communication with the US Food and Drug Administration (FDA)on the SHIELD I Phase III data, the Company now has clarity regarding the regulatory pathway toward a potential New Drug Application (NDA) submission
• In August 2022, ADVANZ PHARMA Corp. Limited signed an exclusive licensing agreement with PolyPid Ltd. ("PolyPid"), a late-stage biopharma company aiming to improve surgical outcomes, under which ADVANZ PHARMA receives the exclusive rights for the commercialization of PolyPid's lead drug candidate, D-PLEX100 for the prevention of surgical site infections ("SSIs") in abdominal and cardiac surgeries, in Europe
Route of Administration
Surgical Site Infections pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Inhalation
• Inhalation/Intravenous/Oral
• Intranasal
• Intravenous
• Intravenous/ Subcutaneous
• NA
• Oral
• Oral/intranasal/subcutaneous
• Parenteral
• Subcutaneous
Molecule Type
Products have been categorized under various Molecule types, such as
• Antibody
• Antisense oligonucleotides
• Immunotherapy
• Monoclonal antibody
• Peptides
• Protein
• Recombinant protein
• Small molecule
• Stem Cell
• Vaccine
Surgical Site Infections Pipeline Therapeutics Assessment
• Surgical Site Infections Assessment by Product Type
• Surgical Site Infections By Stage and Product Type
• Surgical Site Infections Assessment by Route of Administration
• Surgical Site Infections By Stage and Route of Administration
• Surgical Site Infections Assessment by Molecule Type
• Surgical Site Infections by Stage and Molecule Type
DelveInsight's Surgical Site Infections Report covers around 5+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Some of the key companies in the Surgical Site Infections Therapeutics Market include:
Key companies developing therapies for Surgical Site Infections are - 3M Co., B. Braun SE, Becton Dickinson and Co., bioMerieux SA, Covalon Technologies Ltd., Getinge AB, Johnson and Johnson, Kimberly Clark Corp., Medline Industries Inc., Medtronic Plc, Metall Zug AG, Molnlycke Health Care AB, Paul Hartmann AG, Prescient Surgical, Sotera Health Co., Stryker Corp., STERIS Plc, Winner Medical Co. Ltd. and others.
Emerging Surgical Site Infections Drugs Under Different Phases of Clinical Development Include:
• CS-0003 Covira Surgical
• SBG003 Sonoran Biosciences
• EP 201 Eupraxia Pharmaceuticals
• XF-73 Destiny Pharma
• D-PLEX POLYPID
Get a Free Sample PDF Report to know more about Surgical Site Infections Pipeline Therapeutic Assessment- https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Surgical Site Infections Pipeline Analysis:
The Surgical Site Infections pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Surgical Site Infections with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Surgical Site Infections Treatment.
• Surgical Site Infections key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Surgical Site Infections Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Surgical Site Infections market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Surgical Site Infections product details are provided in the report. Download the Surgical Site Infections pipeline report to learn more about the emerging Surgical Site Infections therapies at:
https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Surgical Site Infections Pipeline Market Drivers
• Rising number of surgeries and the growing geriatric population
• Increasing concern about hospital acquired infections along with rising incidences of hospital-acquired infections
Surgical Site Infections Pipeline Market Barriers
• Lack of awareness regarding infection control measures
• Difficulty in identifying the site of infection
Scope of Surgical Site Infections Pipeline Drug Insight
• Coverage: Global
• Key Surgical Site Infections Companies: Covira Surgical, Sonoran Biosciences, Eupraxia Pharmaceuticals, Destiny Pharma, POLYPID, and others
• Key Surgical Site Infections Therapies: CS-0003, SBG003, EP 201, XF-73, D-PLEX, and others
• Surgical Site Infections Therapeutic Assessment: Surgical Site Infections current marketed and Surgical Site Infections emerging therapies
• Surgical Site Infections Market Dynamics: Surgical Site Infections market drivers and Surgical Site Infections market barriers
Request for Sample PDF Report for Surgical Site Infections Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Surgical Site Infections Report Introduction
2 Surgical Site Infections Executive Summary
3 Surgical Site Infections Overview
4 Surgical Site Infections- Analytical Perspective In-depth Commercial Assessment
5 Surgical Site Infections Pipeline Therapeutics
6 Surgical Site Infections Late Stage Products (Phase II/III)
7 Surgical Site Infections Mid Stage Products (Phase II)
8 Surgical Site Infections Early Stage Products (Phase I)
9 Surgical Site Infections Preclinical Stage Products
10 Surgical Site Infections Therapeutics Assessment
11 Surgical Site Infections Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Surgical Site Infections Key Companies
14 Surgical Site Infections Key Products
15 Surgical Site Infections Unmet Needs
16 Surgical Site Infections Market Drivers and Barriers
17 Surgical Site Infections Future Perspectives and Conclusion
18 Surgical Site Infections Analyst Views
19 Appendix
20 About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report to know more about Surgical Site Infections drugs and therapies- https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports:
Surgical Site Infections Market https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Surgical Site Infections-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Surgical Site Infections Epidemiology https://www.delveinsight.com/report-store/surgical-site-infections-ssi-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Surgical Site Infections Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Related Reports By DelveInsight -
Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Hypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Lung Fibrosis Market https://www.delveinsight.com/report-store/lung-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Lung Fibrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lung Fibrosis, historical and forecasted epidemiology as well as the Lung Fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Anterior Uveitis Market https://www.delveinsight.com/report-store/anterior-uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
22q11.2 deletion syndrome Market https://www.delveinsight.com/report-store/22q112-deletion-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "22q11.2 Deletion Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the 22q11.2 Deletion Syndrome, historical and forecasted epidemiology as well as the 22q11.2 Deletion Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
X-Linked Retinitis Pigmentosa (XLRP) Market https://www.delveinsight.com/report-store/x-linked-retinitis-pigmentosa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "X-Linked Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the X-Linked Retinitis Pigmentosa (XLRP), historical and forecasted epidemiology as well as the X-Linked Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry
https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surgical Site Infections Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2952719 • Views: …
More Releases from DelveInsight Business Research
Wilson's Disease Market Analysis 2034 - Competitive Landscape, Clinical Trials, …
DelveInsight reports that approximately 8,000 diagnosed prevalent cases of Wilson's Disease were recorded in the 7MM in 2023, with numbers projected to rise through 2034. The United States leads the market with a 2023 valuation of about USD 126 million, expected to grow at a CAGR of 13%. Current treatment mainly involves chelating agents and zinc salts, with chelating agents dominating the U.S. market at around USD 123 million. Recent…
Biktarvy Market and Sales Forecast: Strong Global Adoption, Expanding Indication …
DelveInsight, a leading business intelligence and market research firm, announced the publication of its latest report, "Biktarvy Market Insights, Sales Forecast, and Competitive Landscape - 2034." The report provides an in-depth commercial, clinical, and strategic outlook on Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide), reinforcing its continued leadership as one of the most widely prescribed HIV therapies worldwide.
As global healthcare systems increasingly adopt simplified antiretroviral regimens to improve adherence and long-term viral suppression, Biktarvy…
Global Biologics Contract Manufacturing Market to reach USD 47,494.63 million at …
According to DelveInsight's analysis, The increasing incidence of chronic conditions such as cancer, diabetes, and autoimmune diseases is driving the demand for biologic therapies, prompting pharmaceutical companies to outsource large-scale production to contract manufacturers. Additionally, the expanding pipeline of biologics-including monoclonal antibodies, vaccines, and biosimilars-necessitates adaptable manufacturing solutions to address rising market demand efficiently. Moreover, advancements in biotechnology and biomedical techniques, such as recombinant DNA technology and enhanced expression systems,…
Global mRNA Synthesis and Manufacturing Market to grow at a CAGR of 4.32% by 203 …
According to DelveInsight's analysis, The growing incidence of infectious diseases, cancer, and chronic disorders has greatly increased the demand for advanced mRNA-based therapies. The surge in mRNA vaccine utilization, particularly following the COVID-19 pandemic, has cemented mRNA technology as a cornerstone in addressing infectious diseases. Moreover, advancements in gene therapy are propelling market growth, as mRNA is essential for delivering therapeutic proteins used in treating genetic and oncological conditions. Its…
More Releases for Surgical
Surgical Robotics Market to Witness Huge Growth by 2031 -Auris Surgical Robotics …
Surgical Robotics Industry Analysis, according DataM Intelligence. Although data provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Will the Surgical Robotics market emerge as the sector's next great thing? To discover the answer, look at the Surgical Robotics market analysis and projections. In-depth…
Surgical Laser Market - Shaping Surgical Precision: Surgical Laser, Guiding the …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Surgical Laser Market.
Surgical Laser Market: https://www.growthplusreports.com/report/surgical-laser-market/9172
The Surgical Laser Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Surgical Retractor Market - Enabling Surgical Mastery: Retractors for Uncompromi …
Newark, New Castle, USA: The "Surgical Retractor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Surgical Retractor Market: https://www.growthplusreports.com/report/surgical-retractor-market/7658
This latest report researches the industry structure, sales,…
Surgical Robots Market Hits USD 17,647.82 million by 2028 Lead By THINK Surgical …
There is a rise in the number of surgeries performed across the world. In the last 25 years, the incidence of cardiovascular diseases has increased globally. The rise in diabetic cases and lifestyle changes are leading to an increase in the number of cardiovascular surgeries and general surgeries. For instance, colorectal cancer is one of the most commonly found and lethal cancers developed in individuals due to the combined influence…
Surgical Robots Market Analysis 2020 - How COVID19 Impacting Surgical Robots Ind …
Report Analyzes Surgical Robots Market Size, Share and Industry Analysis By Type (Implantable Cardioverter Surgical Robots (ICD), Transvenous ICD, External Surgical Robots) By End User (Hospitals & Clinics, Ambulatory, Schools and other Public Places) and Regional Forecast, 2019 - 2026.
Get Sample Report To Know The Impact of Covid19 on this Industry at: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/surgical-robots-market-100948
Key Players: Intuitive Surgical, Medtronic, Stryker, Smith & Nephew, Zimmer Biomet, TransEnterix Surgical, Inc Verb Surgical, THINK Surgical.
An…
Surgical Microscope Market Size, Surgical Microscope Market Share, Surgical Micr …
The global surgical microscope market was valued at USD 610.3 million in 2017 and is estimated to grow at a CAGR of 12.5% during the forecast period 2017-2026.
Request for Sample of This Research Report @ https://bit.ly/2xjcXML
Top Key Players:-
Carl Zeiss AG,
Leica Microsystems,
Takagi Corporation,
Seiler Precision Microscopes,
Topcon Corporation,
Alltion (Wuzhou) Co. Ltd.,
Alcon Laboratories, Inc.,
Haag-Streit Surgical,
Olympus Corporation,
Accu-scope, Inc.,
Novartis AG,
Danaher Corporation,
Labomed Microscopes,
Prescott’s Inc.,…
